BovRes BR-1 BovResonator:
A Bio-Digital Platform for Proactive
Livestock Disease Management
Burmain Holdings (Pty) Ltd — Techno Park, Stellenbosch, South Africa
Executive Summary
BovRes is a 4IR agricultural technology company developing the BR-1 BovResonator — a smart livestock collar that detects Foot and Mouth Disease (FMD) 48 hours before physical symptoms appear, then neutralizes viral replication using precision scalar-wave technology. No chemicals. No culling. No export disruption.
Foot and Mouth Disease is the single most economically destructive livestock disease on the planet, affecting 77% of the global livestock population across Africa, Asia, and South America. A single confirmed outbreak in South Africa triggers automatic international export bans, costing the industry billions in lost trade revenue. The current industry response — reactive culling — destroys wealth, eliminates irreplaceable genetic lineages, and provides no protection against the next outbreak.
BR-1 represents a paradigm shift: from reactive chemical intervention to proactive energetic resilience. The platform combines Ultraweak Biophoton Emission (UBE) sensing, AI-driven gait analysis, bio-impedance monitoring, and the proprietary Scalar-Homeopathic Encoding Algorithm (SHEA) — broadcasting phase-inverted scalar waves that create destructive interference with the FMD virus frequency signature at the cellular level.
The company is raising R3.5M in seed capital to establish its R&D laboratory at Techno Park, Stellenbosch, and launch a 50-unit proof-of-concept trial with Grasslands Agriculture. A Technology Innovation Agency (TIA) co-funding proposal has been submitted. Series A at R15M follows in Year 2, funding a 5,000-unit manufacturing run and full SaaS platform launch.
The Problem: A Billion-Rand Crisis in Plain Sight
Foot and Mouth Disease is endemic across 77% of the world's livestock territory. It is the most feared livestock disease in international trade — not because of mortality rates, but because of the catastrophic economic consequences of a single confirmed case.
The Scale of the Crisis
FMD affects cattle, sheep, goats, pigs, and over 70 other cloven-hoofed species. It spreads with exceptional speed — airborne transmission up to 60km under favorable wind conditions. A single infected animal can expose an entire commercial herd within 24 hours. By the time a farmer observes clinical symptoms (blistering, lameness, excessive salivation), the exposure window has been open for – days.
- R5M—R10M in livestock value destroyed
- Production drop of 2–0% during recovery
- Irreplaceable genetic lineages eliminated via culling
- – months of farm operational disruption
- Automatic international export ban on confirmation
- Loss of FMD-free status requires –2 months to restore
- Regional industry shut-down beyond the infected farm
- South Africa exports R15B+ in animal products annually
Why Current Solutions Fail
The livestock industry currently relies on three inadequate responses:
- Reactive culling: The most common response. Destroys wealth, genetics, and does nothing to prevent re-infection. A cure as destructive as the disease.
- Vaccination: Provides partial protection but critically disqualifies vaccinated animals from export certification under OIE protocols. The "vaccine trap" forces farmers to choose between herd protection and trade access.
- Manual observation: Farmers observe animals – times daily. Symptoms appear – days post-infection. By observation, full herd exposure is complete.
South Africa's Unique Vulnerability
South Africa occupies a unique position: it has historically maintained FMD-free zones in the Western Cape and parts of KwaZulu-Natal, enabling premium export access to the EU and UK. This status is worth billions annually. The Natal Midlands, Western Cape, and Eastern Cape dairy regions represent the most economically valuable livestock zones — and the zones most at risk from a single cross-border introduction of FMD from Zimbabwe or Mozambique.
Scientific Foundation
BR-1 is built on four distinct scientific disciplines: biophoton biology, scalar electromagnetic field theory, digital homeopathy, and AI-driven precision livestock monitoring. Each discipline provides a measurable, validated mechanism of action.
3.1 Ultraweak Biophoton Emission (UBE)
All living cells emit ultraweak photon radiation — biophotons — as a byproduct of metabolic and oxidative processes. Healthy cells emit coherent, low-noise biophoton signals with predictable temporal patterns. Cells under viral attack — oxidative stress caused by viral replication — show measurable disruption in biophoton coherence: increased noise (Fano factor elevation), reduced photon storage capacity, and loss of circadian rhythm in emission patterns.
PMT (Photomultiplier Tube) sensors can detect this coherence loss with high sensitivity. BR-1 uses miniaturized PMT-analog sensors positioned against the coronary band (above the hoof) and muzzle — primary FMD infection sites — to continuously monitor biophoton coherence in real time. A drop below threshold triggers the prodromal alert protocol.
3.2 Scalar Wave Theory & Phase Inversion
Conventional electromagnetic waves (Hertzian waves) are transverse — oscillating perpendicular to their direction of travel. Scalar waves, described in the work of Nikola Tesla and further developed in modern bio-electromagnetic research, are longitudinal — oscillating parallel to propagation direction. Longitudinal waves penetrate biological tissue with significantly lower attenuation than transverse waves, enabling deep-tissue interaction at very low power levels (<10mW).
Every biological entity — including viruses — has a characteristic resonant frequency signature determined by its molecular geometry. By generating a scalar wave at the precise phase-inverse (180— phase shift) of the FMD virus signature, BR-1's SHEA Algorithm creates destructive interference at the molecular level, disrupting the viral replication environment without chemical intervention.
The Caduceus-wound bifilar coil — the core antenna element of BR-1 — generates these non-Hertzian longitudinal scalar waves through counter-winding geometry that causes conventional transverse wave components to cancel, leaving only the scalar (longitudinal) component. Graphene-coated copper wire provides the high-Q resonance required for precision frequency control.
3.3 Digital Homeopathy & Scalar Nosodes
Homeopathic remedies exert their effect through information transfer — the energetic pattern of the original substance imprinted into a carrier medium. Digital homeopathy encodes these energetic patterns as digitized frequency signatures that can be broadcast via scalar wave. BR-1 encodes a proprietary remedy complex — Variolinum 200C (viral nosode), Rhus Toxicodendron 30C (connective tissue support), and Arsenicum Album 30C (systemic detoxification) — into the scalar broadcast signal.
This "digital nosode" serves as an immune primer: stimulating the animal's innate immune response without chemical injection, and without altering serological status (DIVA compliance is maintained). Healthy animals in the herd receive this immune-priming signal as a prophylactic broadcast across the 50-metre mesh network.
3.4 AI Circadian Optimization
Livestock exhibit predictable circadian rhythms in immune function, cortisol levels, and biophoton emission patterns. BR-1's n8n-orchestrated AI layer maps each animal's individual circadian baseline during the first 7 days of deployment. Intervention protocols — broadcast timing, frequency modulation, and power levels — are then synchronized to each animal's optimal therapeutic window (typically during deep rest phases when the parasympathetic nervous system is dominant and receptivity to energetic input is highest).
Technology Architecture
BR-1 integrates eight precision subsystems into a single IP68-rated wearable collar. Each subsystem contributes a distinct layer to the detection-intervention-recovery pipeline.
Scalar-Homeopathic Encoding Algorithm. The proprietary IP core of BR-1. Drives the Caduceus bifilar coil to generate longitudinal scalar waves at the phase-inverse of the FMD frequency signature. Creates destructive interference at the cellular level.
PMT-analog sensors at the coronary band and muzzle. Continuously monitors cellular biophoton coherence. Detects oxidative stress signature 48 hours before visible FMD symptoms. Fano factor analysis confirms return to healthy state post-treatment.
6-axis accelerometer captures stride patterns at 50Hz. Trained ML model detects weight-shifting asymmetry unique to early FMD hoof lesion formation — a behavioural signature that emerges before lameness becomes visible to the human observer.
Measures skin electrical resistance across the coronary band. Viral replication triggers measurable drop in conductance as cellular membrane integrity is compromised. Provides a secondary confirmation signal to UBE readings.
868/915 MHz long-range, low-power mesh. Collars self-organize into a peer-to-peer mesh, enabling herd-wide synchronization with <100ms latency. Gateway connects to Herd-Link cloud via cellular or optional LEO satellite (Starlink) backhaul.
All health logic automation is handled by n8n workflows running on a Burmain Technologies-owned Ubuntu 22.04 server. Triggers alert push notifications, activates virtual fence GPS quarantine, initiates intervention broadcast protocols, and escalates to recovery monitoring — zero manual intervention required.
Graphene-coated copper Caduceus-wound bifilar coil. Graphene's exceptional electrical conductivity and low resistance enable high-Q resonance required for precise scalar frequency control. Supplied by SabiNano — South Africa's leading nanotech supplier.
Proprietary frequency library encoding homeopathic remedy signatures: Variolinum 200C (viral nosode), Rhus Tox 30C, Arsenicum Album 30C. Broadcast as scalar immune primers to healthy herd animals within 50m radius. DIVA-compliant — no serological alteration.
Software Stack
| Layer | Technology | Purpose |
|---|---|---|
| Operating System | Ubuntu 22.04 LTS + Virtualmin Pro | Local server sovereignty, multi-domain management |
| Workflow Engine | n8n (self-hosted) | AI health logic automation, alert triggers, protocol execution |
| Primary Database | MariaDB (time-series optimized) | Animal health records, telemetry storage |
| Vector Store | ChromaDB | RAG-based AI reasoning for anomaly detection |
| Mobile/Web App | Next.js PWA | Herd-Link dashboard (iOS + Android compatible) |
| Firmware | ESP32-S3 (FreeRTOS) | On-device sensor fusion and LoRaWAN communication |
| Connectivity | LoRaWAN 1.2 + optional Starlink | Remote farm coverage without cellular dependency |
| Data Sovereignty | Burmain Technologies | All data processed on Burmain-owned SA servers — no foreign cloud |
Product Specification: BR-1 BovResonator
The BR-1 BovResonator is an IP68-rated smart collar designed for continuous wear in commercial livestock environments. All components are selected for agricultural durability, local sourcing preference (8–0% South African), and cost-efficiency at scale.
| Parameter | Specification | Notes |
|---|---|---|
| Device Type | Smart Collar Wearable | Fits cattle, sheep, goats, pigs |
| IP Rating | IP68 | Waterproof, dustproof, agricultural-grade |
| Housing Material | ASA/TPU composite | UV-resistant, flexible, impact-resistant |
| Transmission Type | Longitudinal Scalar Wave (Non-Hertzian) | Deep tissue penetration at <10mW |
| Antenna | Caduceus bifilar, graphene-coated copper | High-Q resonance, SabiNano supply |
| RF Power Output | <10mW | Short Range Device compliant |
| Battery | LiFePO4 18650 (1500mAh) | Safe chemistry, no thermal runaway risk |
| Energy Harvesting | LTC3588 piezoelectric harvester | Extends battery via animal movement |
| Connectivity | LoRaWAN 868/915 MHz | + optional LEO satellite (Starlink) backhaul |
| Network Latency | <100ms herd-wide sync | Peer-to-peer mesh topology |
| MCU | ESP32-S3 | Dual-core, on-device ML inference |
| Sensors | Thermal IR, UBE PMT-analog, GSR, Bio-Impedance (AD5933), 6-axis IMU | Multi-modal fusion |
| Shield Radius | 50 metres per collar | Mesh network extends coverage |
| BOM Cost | R650 (approx. $37 USD) | 8–0% locally sourced |
| MSRP | R1,500 — $149 USD | ~75% gross margin |
Bill of Materials Summary
- ESP32-S3 module (Mantech Electronics / RS SA)
- AD9833 DDS signal generator (frequency synthesis)
- AD5933 bio-impedance IC
- PMT-analog biophoton sensor (custom)
- 6-axis IMU (LSM6DSO)
- LoRa transceiver (SX1276)
- LTC3588 piezoelectric harvester IC
- LiFePO4 18650 cell
- Graphene ribbon (SabiNano — LoI signed)
- Caduceus bifilar coil winding (M&C Winders / Cape Armature)
- ASA/TPU housing (SA Filament / Fil X 3D printing)
- IP68 gaskets and sealing compounds
- PCB fabrication (local SA supplier)
- Agricultural-grade collar strap
- Connectors and passive components
Detection & Intervention Protocol
BR-1 follows a five-phase automated response pipeline — from continuous baseline monitoring through active treatment and recovery verification. Every phase is triggered and executed by the n8n AI orchestration layer without manual intervention.
Phase 1: Continuous Baseline Monitoring
During the first 7 days of deployment, BR-1 maps each animal's individual circadian biophoton rhythm, gait baseline, and bio-impedance profile. This individualized baseline eliminates false positives caused by natural variation between animals. The AI adjusts all subsequent alert thresholds to the individual animal's profile.
Phase 2: Prodromal Detection (T-48hrs)
When UBE coherence drops below threshold (combined with corroborating gait or bio-impedance signals), the system classifies the animal as "Yellow Alert." A push notification is sent to the farm manager via Herd-Link. GPS tracking is activated. The collar increases its broadcast power to maximum therapeutic intensity for the affected animal.
General Herd — Healthy baseline — Prophylactic scalar pulse every 6 hours — Digital nosode broadcast (immune primer)
Buffer Animals within 10m — High-potency Homeopathic Shield (Aconite 200C) — Increased monitoring frequency — Alert status
Infected Animal — Maximum Inversion Therapy (180— phase-inversion at 100% power) — Virtual fence quarantine — Intensive recovery monitoring
The First 60 Minutes: Automated Response Timeline
UBE coherence drops below threshold. Red Zone alert triggered. Push notification sent to farm manager. Infected collar switches to Max Gain Inversion Therapy at 100% power.
Virtual fence GPS quarantine zone established (500m radius). Adjacent collars (within 10m) enter Yellow Zone protocol — Aconite 200C homeopathic shield activated.
All Green Zone collars begin broadcasting Variolinum 200C digital nosode — collective immune-priming signal. Herd-wide synchronization latency <100ms via LoRaWAN mesh.
Farm manager deploys structured water and physical remedy support to infected animal. Herd-Link provides step-by-step protocol guidance in the app.
System measures biophoton noise reduction in infected animal. If UBE coherence is improving, protocol continues. If no improvement detected, escalation alert is sent for veterinary consultation.
Collar transitions to Lymphatic Drainage Frequency (8Hz PEMF). Assists cellular clearance of viral debris. Monitoring continues until biophoton coherence returns to individual baseline and Fano factor normalizes to approximately 1.
Laboratory Validation Protocol
The 50-unit Grasslands Agriculture pilot will be preceded by laboratory validation in the Techno Park R&D facility. The validation protocol uses bovine epithelial cell cultures across four cohorts in a Faraday cage environment (-20—C to eliminate thermal noise):
| Cohort | Condition | Target Outcome |
|---|---|---|
| Control A | Healthy, untreated | Baseline biophoton coherence reference |
| Control B | FMD-infected, untreated | Confirms biophoton noise elevation (Fano >2) |
| Test C | FMD-infected + SHEA treatment | >50% UPE reduction — Fano — 1 — 72hrs |
| Test D | Healthy + prophylactic scalar shield | Enhanced photon storage (delayed luminescence) |
Market Analysis
BovRes enters at the intersection of three high-growth markets: precision livestock farming, agricultural biosecurity, and FMD-endemic region trade protection. The addressable opportunity is both large and urgent.
Primary Market Segments
| Segment | Size | BovRes Entry Point |
|---|---|---|
| Large-scale dairy herds (500+ head) | High value genetics — FMD risk premium | Direct sales + Herd-Link SaaS |
| Commercial feedlots (export-grade) | Export certification critical | DIVA-compliance value proposition |
| Government biosecurity agencies (DALRRD) | R4.5B SA livestock tech market | Government tender + co-funding (TIA) |
| Regional cooperatives (Natal Midlands, Western Cape) | Collective risk management | Cooperative bulk licensing |
| SADC regional expansion (Year 2) | Zimbabwe, Zambia, Botswana, Namibia | Distribution partnerships |
| EU/UK markets (Year 3) | VHR registration pathway | Digital nosode regulatory approval |
Competitive Landscape
| Solution | Detection Timing | Intervention | DIVA Compliant | Export Impact |
|---|---|---|---|---|
| BR-1 BovResonator | 48hrs pre-symptom | Scalar wave (non-chemical) | ✅ Yes | No restriction |
| FMD Vaccine | Preventative only | Chemical injection | ❌ No | Disqualifies export |
| CowManager / SCR | Post-symptom | None (alert only) | ✅ Yes | No restriction |
| Manual observation | – days post-infection | Culling / vet call | ✅ Yes | Herd destruction |
Demand Drivers
- Anti-antibiotic legislation: EU and UK bans on prophylactic antibiotic use in livestock create demand for non-chemical alternatives
- Export certification requirements: WOAH protocols require FMD-free certification for premium market access — BR-1 protects this status
- Climate-driven FMD spread: Changing rainfall patterns and wildlife migration routes are expanding FMD endemic zones southward into historically FMD-free areas
- 4IR agricultural adoption: SA government's Agriculture and Agro-Processing Master Plan explicitly targets smart farming technology adoption
- TIA and DALRRD funding: Government biosecurity modernisation budgets actively fund qualifying agricultural technology
Business Model
BovRes operates a four-layer revenue model designed to compound: hardware margins fund SaaS growth, SaaS funds VaaS licensing, and licensing scales without manufacturing constraints.
BR-1 collar at R1,500 MSRP. BOM ranges from R1,400 (pilot, 50 units) to R650 at production scale (1,000+ units), delivering margins of ~7% at pilot and ~57% at scale. Revenue recognized at point of sale. Sold direct to large operations and via cooperative bulk licensing.
Per-herd monthly subscription to the Herd-Link dashboard and AI health platform. Includes automated SHEA algorithm updates pushed via cloud, telemetry storage, and n8n workflow automation. Recurring revenue grows with every active collar.
Annual maintenance kits: graphene antenna ribbon replacement, LiFePO4 battery pack, sensor calibration module. High-margin, predictable demand. Every active collar generates annual consumable revenue.
Vitality-as-a-Service: license the SHEA Algorithm and proprietary frequency library to existing global livestock wearable manufacturers (CowManager, SCR by Allflex, etc.). Pure software revenue — no manufacturing cost. This is the Year 3+ scaling play.
Unit Economics
| Metric | Value | Notes |
|---|---|---|
| MSRP (SA market) | R1,500 | Local commercial pricing |
| MSRP (Export / USD) | $149 | International pricing |
| BOM cost | R650–R1,400 | R650 at scale (1,000+ units) · 80%+ SA sourced |
| Gross margin | ~57% at scale | R850 margin at R650 BOM · ~7% at pilot stage |
| Annual consumable revenue per collar | ~R250 | Maintenance kit |
| SaaS revenue per herd (100 collars) | TBD at pilot | Monthly subscription |
| VaaS licensing rate | TBD at Series A | Per-unit royalty structure |
Financial Projections
Three-year financial trajectory from seed validation through market dominance. All figures in South African Rand (ZAR). Year 1 is deliberately loss-making — capital is deployed for validation, not revenue optimisation.
| Year | Revenue | EBITDA |
|---|---|---|
| Year 1 | R250K | (R3.4M) — investment phase |
| Year 2 | R18.5M | R4M positive |
| Year 3 | R145M | R75M positive |
Seed Round Deployment (R3.5M)
| Category | Allocation | Purpose |
|---|---|---|
| Techno Park Lab / Office | R750,000 | 18-month lease, fit-out, equipment housing |
| Precision Equipment | R950,000 | Helmholtz cage, CNC coil winder, oscilloscopes, Faraday cage |
| Core Team (12 months) | R1,200,000 | Lead Engineer, Riccardo De Wet (Lead Physicist), Lab Technician |
| Materials & BOM | R350,000 | 50-unit pilot components, graphene, PCB fabrication |
| Legal / IP / Regulatory | R250,000 | PCT filing, ICASA, SABS, WOAH submission |
| Total | R3,500,000 |
A TIA (Technology Innovation Agency) co-funding proposal has been submitted. If approved, TIA matching would reduce private investor exposure by up to 50% of the seed amount, with no equity dilution for the TIA contribution.
Regulatory & Compliance Strategy
BR-1 is positioned as a Precision Livestock Monitoring (PLM) tool — not a veterinary pharmaceutical device. This classification avoids the multi-year pharmaceutical trial requirements while enabling a clear compliance pathway across all target markets.
Submit BR-1 for WOAH (World Organisation for Animal Health) Emerging Technology programme. Classification as PLM tool — not pharmaceutical. PVS pathway engagement initiated.
ICASA technical specification filing for LoRaWAN 868/915 MHz operation. SABS certification for non-ionizing resonant device classification. DALRRD "Alternative Protocol" status application.
Submit laboratory validation results to a bio-physics or veterinary science journal. Peer review establishes scientific credibility for WOAH and VHR registration applications.
Veterinary Homeopathic Remedy registration for digital nosode broadcast components in EU and UK markets. Complies with Directive 2001/82/EC framework for VHRs.
Full ISO 17025 accreditation for the Techno Park laboratory. Elevates validation data to internationally recognised standard. Critical for Series A investor confidence and WOAH pathway.
Intellectual Property & Patent Strategy
The BovRes IP moat is built on four distinct patent claims, a proprietary frequency library, and the structural advantage that the SHEA Algorithm requires 18+ months of biophoton calibration data to replicate — data that only BovRes possesses.
Patent Claims (Provisional Filed — Global IP Co)
- Claim 1: Method for neutralizing viral pathogens in livestock via phase-inversion scalar wave broadcast, integrating UBE feedback control
- Claim 2: Wearable device comprising a Caduceus bifilar coil antenna for non-Hertzian scalar wave generation in a livestock collar form factor
- Claim 3: Automated herd-management AI system integrating biophoton coherence sensing with scalar therapeutic intervention and virtual fencing
- Claim 4: Graphene-coated copper antenna system optimized for high-Q scalar resonance in biological field applications
IP Timeline
| Milestone | Timeline | Status |
|---|---|---|
| Provisional patent filing (SA) | Completed | ✅ Filed — Global IP Co |
| PCT (Patent Cooperation Treaty) international filing | Q3 2026 | In progress |
| US patent prosecution | Q1 2027 | Planned |
| EU patent prosecution | Q1 2027 | Planned |
| Trademark: "Herd-Link", "BovResonator", "HerdShield" | Q2 2026 | Planned |
| Trade secret: SHEA frequency library | Ongoing | Protected internally |
Trademarked Assets
- BovRes (brand name)
- BovResonator (product name)
- Herd-Link (software platform)
- HerdShield (herd protection brand)
- SHEA Algorithm (algorithm designation)
Investment Terms & Structure
BovRes is raising R3.5M in seed capital from a maximum of five investors. The round is structured to validate technology, launch the 50-unit pilot, and position the company for a R15M Series A in Year 2.
Equity Tier Structure
| Tier | Equity | Investment | Availability |
|---|---|---|---|
| Entry | 5% | R175,000 | Available |
| Growth | 8% | R280,000 | Available |
| Partner | 12% | R420,000 | Available |
| Strategic | 18% | R630,000 | Available |
| Lead | 25% | R875,000 | Available |
Instrument & Rights
- Convertible equity / Class B ordinary shares
- Non-voting on operational matters
- Full economic rights (dividends, exit proceeds)
- Anti-dilution protection at Series A
- Information rights: quarterly financial reporting
- Pro-rata rights in Series A round
- Strategic acquisition: Zoetis, Merck Animal Health, Elanco
- SHEA Algorithm licensing to incumbent manufacturers
- Management buyout at Series B valuation
- Target horizon: – years to liquidity event
- Exit multiple: –2— EBITDA (AgTech sector average)
Key Investment Milestones
Techno Park facility operational. Lead Engineer and Riccardo De Wet (Lead Physicist) onboarded. Helmholtz cage and Faraday cage installed. Graphene ribbon supply commenced (SabiNano).
Cell-culture validation of SHEA phase-inversion achieves >50% UPE reduction in Test C cohort. Results submitted for peer review. ICASA and SABS certification filed.
50 BR-1 collars deployed across Grasslands Agriculture farms. 30-day baseline mapping. Real-world biophoton monitoring commenced. Pilot data collected for Series A prospectus.
Backed by pilot data and lab validation. Funds 5,000-unit manufacturing run, full Herd-Link SaaS launch, and SADC regional expansion.